FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ernesto Cano

Research Profile

Chemicals & Drugs

Physiology

Concepts & Ideas

Anatomy

Living Beings

Occupations

Drug Design

Co-author Network

Publications

TOP 3
Abdelaziz El Maatougui; Vicente Yaziji; Carmen López; Matilde Yañez; Jhonny Azuaje; Ernesto Cano; Carlos Carbajales; Alberto Coelho; Eddy Sotelo
Discovery and preliminary SAR of 5-arylidene-2,2-dimethyl-1,3-dioxane- 4,6-diones as platelet aggregation inhibitors.
Caroline Meyers; Matilde Yáñez; Abdelaziz Elmaatougi; Tom Verhelst; Alberto Coelho; Matilde Yañez; Guy Lemière; Xerardo García-Mera; Reyes Laguna; Ernesto Cano; Bert U W Maes; Eddy Sotelo
2-Substituted 4-, 5-, and 6-[(1E)-3-oxo-3-phenylprop-1-en-1-yl]pyridazin-3(2H)-ones and 2-substituted 4,5-bis[(1E)-3-oxo-3-phenylprop-1-en-1-yl]pyridazin-3(2H)-ones as potent platelet aggregation inhibitors: design, synthesis, and SAR studies.
Alberto Coelho; Enrique Raviña; Matilde Yañez; Matilde Yáñez; Reyes Laguna; Ernesto Cano; Eddy Sotelo
Design, synthesis, and structure-activity relationships of a novel series of 5-alkylidenepyridazin-3(2H)-ones with a non-cAMP-based antiplatelet activity.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ernesto Cano (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Abdelaziz El Maatougui; Vicente Yaziji; Carmen López; Matilde Yañez; Jhonny Azuaje; Ernesto Cano; Carlos Carbajales; Alberto Coelho; Eddy Sotelo
Discovery and preliminary SAR of 5-arylidene-2,2-dimethyl-1,3-dioxane- 4,6-diones as platelet aggregation inhibitors.
Combinatorial chemistry & high throughput screening 2012;15(7):551-4.
2008: Caroline Meyers; Matilde Yáñez; Abdelaziz Elmaatougi; Tom Verhelst; Alberto Coelho; Matilde Yañez; Guy Lemière; Xerardo García-Mera; Reyes Laguna; Ernesto Cano; Bert U W Maes; Eddy Sotelo
2-Substituted 4-, 5-, and 6-[(1E)-3-oxo-3-phenylprop-1-en-1-yl]pyridazin-3(2H)-ones and 2-substituted 4,5-bis[(1E)-3-oxo-3-phenylprop-1-en-1-yl]pyridazin-3(2H)-ones as potent platelet aggregation inhibitors: design, synthesis, and SAR studies.
Bioorganic & medicinal chemistry letters 2008;18(2):793-7.
2007: Alberto Coelho; Enrique Raviña; Matilde Yañez; Matilde Yáñez; Reyes Laguna; Ernesto Cano; Eddy Sotelo
Design, synthesis, and structure-activity relationships of a novel series of 5-alkylidenepyridazin-3(2H)-ones with a non-cAMP-based antiplatelet activity.
Journal of medicinal chemistry 2007;50(26):6476-84.
2006: J Fernando Padín; Miguel A Rodríguez; Eduardo Domínguez; Iria G. Dopeso Reyes; Montserrat Buceta; Ernesto Cano; Eddy Sotelo; José Brea; Hector Caruncho; M Isabel Cadavid; Marian Castro; M Isabel Loza
Parallel regulation by olanzapine of the patterns of expression of 5-HT2A and D3 receptors in rat central nervous system and blood cells.
Neuropharmacology 2006;51(4):923-32.
2006: Matilde Yáñez; Nuria Fraiz; Ernesto Cano; Matilde Yañez
(-)-Trans-epsilon-viniferin, a polyphenol present in wines, is an inhibitor of noradrenaline and 5-hydroxytryptamine uptake and of monoamine oxidase activity.
European journal of pharmacology 2006;542(1-3):54-60.
2006: Matilde Yáñez; Nuria Fraiz; Ernesto Cano; Matilde Yañez
Inhibitory effects of cis- and trans-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity.
Biochemical and biophysical research communications 2006;344(2):688-95.
2006: Christilla Bachelot-Loza; Perrine Badol; Brigitte Brohard-Bohn; Nuria Fraiz; Ernesto Cano; Francine Rendu
Differential regulation of platelet aggregation and aminophospholipid exposure by calpain.
British journal of haematology 2006;133(4):419-26.
2006: Abel Crespo; Caroline Meyers; Alberto Coelho; Matilde Yáñez; Matilde Yañez; Eddy Sotelo; Bert U W Maes; Reyes Laguna; Ernesto Cano; Guy Lemière; Enrique Raviña
Pyridazines part 41: synthesis, antiplatelet activity and SAR of 2,4,6-substituted 5-(3-oxo-3-phenylprop-1-en-1-yl)- or 5-(3-phenylprop-2-enoyl)pyridazin-3(2H)-ones.
Bioorganic & medicinal chemistry letters 2006;16(4):1080-3.
2006: Santiago Vilar; Elías Quezada; Lourdes Santana; Eugenio Uriarte; Matilde Yánez; Nuria Fraiz; Carlos Alcaide; Ernesto Cano; Matilde Yañez
Design, synthesis, and vasorelaxant and platelet antiaggregatory activities of coumarin-resveratrol hybrids.
Bioorganic & medicinal chemistry letters 2006;16(2):257-61.
2004: José Leiro; Ernesto Cano; Florencio M Ubeira; Francisco Orallo; Manuel L Sanmartín
In vitro effects of resveratrol on the viability and infectivity of the microsporidian Encephalitozoon cuniculi.
Antimicrobial agents and chemotherapy 2004;48(7):2497-501.
2004: José Leiro; Ezequiel Alvarez; Juan A Arranz; Ernesto Cano; Francisco Orallo
Antioxidant activity and inhibitory effects of hydralazine on inducible NOS/COX-2 gene and protein expression in rat peritoneal macrophages.
International immunopharmacology 2004;4(2):163-77.
2004: Alberto Coelho; Eddy Sotelo; Matilde Yañez; Matilde Yáñez; Reyes Laguna; Ernesto Cano; Enrique Raviña
Pyridazines. Part 36: Synthesis and antiplatelet activity of 5-substituted-6-phenyl-3(2H)-pyridazinones.
Bioorganic & medicinal chemistry letters 2004;14(2):321-4.
2002: Eddy Sotelo; Matilde Yañez; Matilde Yáñez; Reyes Laguna; Ernesto Cano; Enrique Raviña
Pyridazines. Part 31: synthesis and antiplatelet activity of 4,5-disubstituted-6-phenyl-3(2H)-pyridazinones.
Chemical & pharmaceutical bulletin 2002;50(12):1574-7.
2002: Eddy Sotelo; Matilde Yañez; Matilde Yáñez; Vicente Terrades; Reyes Laguna; Ernesto Cano; Enrique Raviña
Pyridazines. Part XXIX: synthesis and platelet aggregation inhibition activity of 5-substituted-6-phenyl-3(2H)-pyridazinones. Novel aspects of their biological actions.
Bioorganic & medicinal chemistry 2002;10(9):2873-82.
2002: Eddy Sotelo; Matilde Yañez; Matilde Yáñez; Reyes Laguna; Ernesto Cano; José Brea; Enrique Raviña
Pyridazines. Part 28: 5-alkylidene-6-phenyl-3(2H)-pyridazinones, a new family of platelet aggregation inhibitors.
Bioorganic & medicinal chemistry letters 2002;12(12):1575-7.
1999: A Montero-Lastres; Nuria Fraiz; Reyes Laguna; Ernesto Cano; I Estevez; Enrique Raviña
Pyridazines. XVIII. 6-Aryl-3(2H)-pyridazinones inhibit calcium influx in stimulated platelets.
Biological & pharmaceutical bulletin 1999;22(12):1376-9.
1999: S Pain; A Monstero-Lastres; Hervé Falet; Brigitte Brohard-Bohn; Nuria Fraiz; Christilla Bachelot-Loza; Ernesto Cano; Francine Rendu
Calpain controls the balance between protein tyrosine kinase and tyrosine phosphatase activities during platelet activation.
FEBS letters 1999;453(1-2):119-23.
1999: Lourdes Santana; Marta Teijeira; Eugenio Uriarte; C Teran; B Liñares; R Villar; Reyes Laguna; Ernesto Cano
AM1 theoretical study, synthesis and biological evaluation of some benzofuran analogues of anti-inflammatory arylalkanoic acids.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 1999;7(2):161-6.
1997: Reyes Laguna; B Rodriguez-Liñares; Ernesto Cano; I Estevez; Enrique Raviña; Eddy Sotelo
Pyridazines. XIII. Synthesis of 6-aryl-5-oxygenated substituted-3(2H)-pyridazinones and evaluation as platelet aggregation inhibitors.
Chemical & pharmaceutical bulletin 1997;45(7):1151-5.